These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 9193880)

  • 1. Inhibitory anti-peptide antibody against human CYP3A4.
    Wang RW; Lu AY
    Drug Metab Dispos; 1997 Jun; 25(6):762-7. PubMed ID: 9193880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory anti-CYP3A4 peptide antibody: mapping of inhibitory epitope and specificity toward other CYP3A isoforms.
    Wang RW; Newton DJ; Liu NY; Shou M; Rushmore T; Lu AY
    Drug Metab Dispos; 1999 Feb; 27(2):167-72. PubMed ID: 9929498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of a potent inhibitory monoclonal antibody to cytochrome P-450 3A4 in assessment of human drug metabolism.
    Mei Q; Tang C; Assang C; Lin Y; Slaughter D; Rodrigues AD; Baillie TA; Rushmore TH; Shou M
    J Pharmacol Exp Ther; 1999 Nov; 291(2):749-59. PubMed ID: 10525096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-function analysis of human CYP3A4 using a specific proinhibitory antipeptide antibody.
    Schulz-Utermoehl T; Mountfield RJ; Bywater RP; Madsen K; Jørgensen PN; Hansen KT
    Drug Metab Dispos; 2000 Jul; 28(7):718-25. PubMed ID: 10859142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antipeptide antibodies against overlapping sequences differentially inhibit human CYP2D6.
    Cribb A; Nuss C; Wang R
    Drug Metab Dispos; 1995 Jul; 23(7):671-5. PubMed ID: 7587952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different contributions of cytochrome P450 2C19 and 3A4 in the oxidation of omeprazole by human liver microsomes: effects of contents of these two forms in individual human samples.
    Yamazaki H; Inoue K; Shaw PM; Checovich WJ; Guengerich FP; Shimada T
    J Pharmacol Exp Ther; 1997 Nov; 283(2):434-42. PubMed ID: 9353355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of human cytochrome P450 3A4 in metabolism of medroxyprogesterone acetate.
    Kobayashi K; Mimura N; Fujii H; Minami H; Sasaki Y; Shimada N; Chiba K
    Clin Cancer Res; 2000 Aug; 6(8):3297-303. PubMed ID: 10955816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epitope mapping studies with human anti-cytochrome P450 3A antibodies.
    Leeder JS; Gaedigk A; Lu X; Cook VA
    Mol Pharmacol; 1996 Feb; 49(2):234-43. PubMed ID: 8632755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progesterone and testosterone hydroxylation by cytochromes P450 2C19, 2C9, and 3A4 in human liver microsomes.
    Yamazaki H; Shimada T
    Arch Biochem Biophys; 1997 Oct; 346(1):161-9. PubMed ID: 9328296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoantibodies against cytochromes P-4502E1 and P-4503A in alcoholics.
    Lytton SD; Helander A; Zhang-Gouillon ZQ; Stokkeland K; Bordone R; Aricò S; Albano E; French SW; Ingelman-Sundberg M
    Mol Pharmacol; 1999 Feb; 55(2):223-33. PubMed ID: 9927612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective and potent inhibition of human CYP2C19 activity by a conformationally targeted antipeptide antibody.
    Schulz-Utermoehl T; Mountfield RJ; Madsen K; Jørgensen PN; Hansen KT
    Drug Metab Dispos; 2000 Jul; 28(7):715-7. PubMed ID: 10859141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of human liver cytochrome P450 isoforms involved in the in vitro metabolism of cyclobenzaprine.
    Wang RW; Liu L; Cheng H
    Drug Metab Dispos; 1996 Jul; 24(7):786-91. PubMed ID: 8818577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative studies of in vitro inhibition of cytochrome P450 3A4-dependent testosterone 6beta-hydroxylation by roxithromycin and its metabolites, troleandomycin, and erythromycin.
    Yamazaki H; Shimada T
    Drug Metab Dispos; 1998 Nov; 26(11):1053-7. PubMed ID: 9806945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biotransformation of parathion in human liver: participation of CYP3A4 and its inactivation during microsomal parathion oxidation.
    Butler AM; Murray M
    J Pharmacol Exp Ther; 1997 Feb; 280(2):966-73. PubMed ID: 9023313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of cytochrome P450 3A4 in human metabolism of MK-639, a potent human immunodeficiency virus protease inhibitor.
    Chiba M; Hensleigh M; Nishime JA; Balani SK; Lin JH
    Drug Metab Dispos; 1996 Mar; 24(3):307-14. PubMed ID: 8820421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Midazolam and triazolam biotransformation in mouse and human liver microsomes: relative contribution of CYP3A and CYP2C isoforms.
    Perloff MD; von Moltke LL; Court MH; Kotegawa T; Shader RI; Greenblatt DJ
    J Pharmacol Exp Ther; 2000 Feb; 292(2):618-28. PubMed ID: 10640299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purification from liver microsomes from untreated cynomolgus monkeys of cytochrome P450 closely related to human cytochrome P450 2B6.
    Ohmori S; Shirakawa C; Motohashi K; Yoshida H; Abe H; Nakamura T; Horie T; Kitagawa H; Asaoka K; Rikihisa T
    Mol Pharmacol; 1993 Feb; 43(2):183-90. PubMed ID: 8429823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro metabolism of quinidine: the (3S)-3-hydroxylation of quinidine is a specific marker reaction for cytochrome P-4503A4 activity in human liver microsomes.
    Nielsen TL; Rasmussen BB; Flinois JP; Beaune P; Brosen K
    J Pharmacol Exp Ther; 1999 Apr; 289(1):31-7. PubMed ID: 10086984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytochrome P450 3A-dependent metabolism of a potent and selective gamma-aminobutyric acid Aalpha2/3 receptor agonist in vitro: involvement of cytochrome P450 3A5 displaying biphasic kinetics.
    Ma B; Polsky-Fisher SL; Vickers S; Cui D; Rodrigues AD
    Drug Metab Dispos; 2007 Aug; 35(8):1301-7. PubMed ID: 17460031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Territrems B and C metabolism in human liver microsomes: major role of CYP3A4 and CYP3A5.
    Peng FC; Chang CC; Yang CY; Edwards RJ; Doehmer J
    Toxicology; 2006 Feb; 218(2-3):172-85. PubMed ID: 16337070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.